The use of a combination of neutraceuticals (Bifidobacterium longum BB536, red yeast rice, niacin, CoQ10) was effective at reducing cardiovascular risk factors when taken over 12 weeks. The probiotic lowers cholesterol absorption.https://t.co/YuO8n3MmEi
RT @NutrJournal: Combined #probiotic and red yeast rice extract supplement may improve #lipidprofile https://t.co/yg8m5Hxb3r https://t.co/…
Combined #probiotic and red yeast rice extract supplement may improve #lipidprofile https://t.co/yg8m5Hxb3r https://t.co/yJezNQBGJ7
It seems a particular strain of bifidobacterium combined with the popular supplemental red rice yeast extract has been shown to drop cardiovascular markers such as high LDL's. A really interesting study that highlights the systemic effect of our... https:/
RT @JoseAntonioPhD: Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacteri…
RT @JoseAntonioPhD: Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacteri…
Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study https://t.co/JEmF1K6G7P
RT @JoseAntonioPhD: Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacteri…
RT @JoseAntonioPhD: Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacteri…
Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study https://t.co/ZNppE4OJ62
Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study https://t.co/c01Bm98nZ8